Hyperion DeFi Reports Q3 2026 Financial Results

Hyperion DeFi reported a third consecutive quarter of record net income for Q3 2026 and achieved breakeven-or-better core operating profit and cash flow one quarter ahead of its year-end guidance. The company repaid approximately $8.6 million in principal and interest to retire its Avenue Capital loan and began repurchasing shares under its previously announced $20 million buyback program. Hyperion also wound down its legacy biotech segment, selling the remaining Optejet intellectual property to Arctic Vision in July.